Advertisement Innogenetics restructures GENimmune pharma division - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Innogenetics restructures GENimmune pharma division

Innogenetics has announced the implementation of its restructuring plan for the pharma division of GENimmune.

Based on the collective labor agreement signed on May 8, 2008 with its social partners, a total of 24 labor contracts will be terminated in a first phase procedure effective June 1, 2008.

On June 1, 2008 the biologicals production unit will be re-integrated into Innogenetics under the name Innogenetics Biologicals.